Although it is still unclear whether low levels of prothrombin, fibrinogen, and FXIII increase bleeding risk in patients with cirrhosis, we propose that structural defects in the fibrin clot may occur when levels become critically low. This evidence concerns the gene F2 and Cirrhosis.